Pharvaris (PHVS) Assets (2020 - 2026)
Pharvaris (PHVS) reported Assets of $304.1 million for Q1 2026, up 16.56% on a YoY basis from $260.9 million in Q1 2025, and down 13.33% quarter-over-quarter from $350.9 million in Q4 2025.
Pharvaris (PHVS) Assets (2020 - 2026) Analysis & Trends
Pharvaris has reported Assets for 7 years, with the latest figure at $304.1 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 16.56% year-over-year to $304.1 million; the trailing twelve-month figure through Mar 2026 stood at $304.1 million (up 16.56% YoY), and the FY2025 full-year result was $340.6 million, up 8.0% from the prior year.
- Assets for Q1 2026 stood at $304.1 million, down from $350.9 million in the prior quarter.
- The five-year high for Assets was $429.0 million in Q4 2023, with the low at $158.6 million in Q1 2023.
- Historically, Assets has averaged $282.0 million across 5 years, with a median of $260.9 million in 2025.
- Annual changes were most pronounced in 2024 — Assets jumped 158.58% — and 2025, when it plunged 37.32%.
- Pharvaris' Assets stood at $171.1 million in 2022, then surged by 150.67% to $429.0 million in 2023, then fell by 27.42% to $311.4 million in 2024, then advanced by 12.7% to $350.9 million in 2025, then slipped by 13.33% to $304.1 million in 2026.
- The last three Assets figures came in at $304.1 million (Q1 2026), $350.9 million (Q4 2025), and $396.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 640.56 Mn |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | 304.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304.15 Mn |
| Dec 31, 2025 | 350.91 Mn |
| Sep 30, 2025 | 396.19 Mn |
| Jun 30, 2025 | 237.50 Mn |
| Mar 31, 2025 | 260.93 Mn |
| Dec 31, 2024 | 311.36 Mn |
| Sep 30, 2024 | 343.94 Mn |
| Jun 30, 2024 | 378.90 Mn |
| Mar 31, 2024 | 410.20 Mn |
| Dec 31, 2023 | 428.97 Mn |
| Sep 30, 2023 | 184.34 Mn |
| Jun 30, 2023 | 206.62 Mn |
| Mar 31, 2023 | 158.64 Mn |
| Dec 31, 2022 | 171.13 Mn |
| Sep 30, 2022 | 204.66 Mn |
| Jun 30, 2022 | 220.61 Mn |
| Mar 31, 2022 | 225.74 Mn |
| Dec 31, 2021 | 242.62 Mn |
| Sep 30, 2021 | 263.09 Mn |
| Jun 30, 2021 | 276.65 Mn |